Compare Johnson & Johnson (JNJ) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Tripadvisor Inc Common Stock — how do they compare? Johnson & Johnson trades at $260.52 (market cap $618.09B), while Tripadvisor Inc Common Stock trades at $8.67 (market cap $1.01B). The key difference: Johnson & Johnson is far larger — about 612× Tripadvisor Inc Common Stock's market cap, and Johnson & Johnson pays a 2.09% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Tripadvisor Inc Common Stock for 57 Days on average.
| JNJ | TRIP | |
|---|---|---|
Market Cap | $618.09B | $1.01B |
Volume | 6,050,983 | 3,004,748 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $16.72 |
52-Week Low | $186.00 | $8.04 |
Typical Hold Time | 129 Days | 57 Days |
Enterprise Value | $646.37B | $1.06B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
TripAdvisor (TRIP) trades at $8.69, up 0.7% on the day, but remains near its 52-week low of $8.27 (Defense World, 2026-09-25). The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported Q2 2026 earnings of $0.35 per share, missing the $0.375 estimate (Zacks Investment Research, 2026-08-06), while revenue trends show modest growth from $1.5B in 2022 to $1.9B in 2025. Analyst sentiment is cautious with a consensus price target of $13.58, implying significant upside potential from current levels.
The outlook for TRIP hinges on its ability to stabilize core business performance amid competitive pressures from AI-driven travel platforms. Investment opportunity lies in the discounted valuation relative to analyst targets, but risks include persistent earnings misses, declining net cash flow, and market share erosion. The completion of TheFork subsidiary sale could provide a near-term catalyst, but execution remains key for shareholder value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
